Trial record 1 of 1 for: "Ectodermal Dysplasia" | "Antibiotics, Antitubercular"
Previous Study | Return to List | Next Study
Topical Sirolimus for the Treatment of Pachyonychia Congenita (PC)
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT02152007|
Recruitment Status : Completed
First Posted : June 2, 2014
Results First Posted : October 7, 2016
Last Update Posted : October 7, 2016
Pachyonychia Congenita Project
Information provided by (Responsible Party):
|Study Design||Allocation: Randomized; Intervention Model: Single Group Assignment; Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor); Primary Purpose: Treatment|
Drug: 1% sirolimus cream (TD201 1%)
This study was primarily concerned with safety endpoints. Efficacy endpoints need to be improved for follow on studies.